Author

Alexandra Zanin‐Zhorov

NYU Langone HealthORCID 0000-0002-9807-7713Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexander SwarbrickiD· 1 shared Alice M. H. Tran· 1 shared Anaiis Zaratzian· 1 shared Andrew Da Silva· 1 shared Anna E. HowelliD· 1 shared Anthony James GilliD· 1 shared Ashwin JainarayananiD· 1 shared Astrid MagenauiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Alexander SwarbrickORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ROCK2 inhibition has a dual role in reducing ECM remodelling and cell growth, while impairing migration and invasion

Daniel A. Reed, Anna E. Howell, Nadia Kuepper, Alice M. H. Tran, Astrid Magenau, Deborah Sim Barkauskas, Max Nobis, Cecilia R. Chambers, Victoria Lee, Lily M. Channon, Jessie Zhu, Shona Ritchie, Janett Stoehr, Kaitlin Wyllie, Julia Chen, , David Herrmann

This paper shows that ROCK2 inhibition reduces ECM remodelling and cell growth while impairing migration and invasion in breast cancer models.

bioRxiv · Jul 21, 2025 · PreprintCell Biology

STAT3 phosphorylation in the rheumatoid arthritis immunological synapse

Hila Novak‐Kotzer, Jesusa Capera, Ashwin Jainarayanan, Viveka Mayya, Alexandra Zanin‐Zhorov, Salvatore Valvo, Joanne Macdonald, Peter Charles Taylor, Michael Loran Dustin

This study identifies a JAK-independent mechanism of STAT3 activation in RA through TCR-dependent phosphorylation at the immunological synapse, suggesting a new therapeutic target.

bioRxiv · Jan 20, 2025 · PreprintImmunology